Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10583900 | 1.00 | — | — | |
| Ethylene SCHEMBL30862405 | 0.92 | — | — | |
| SCHEMBL18187089 | 0.91 | — | — | |
| SCHEMBL18187078 | 0.91 | — | — | |
| SCHEMBL8335757 | 0.91 | — | — | |
| SCHEMBL18187385 | 0.91 | — | — | |
| SCHEMBL18187185 | 0.91 | — | — | |
| SCHEMBL18188042 | 0.91 | — | — | |
| SCHEMBL7735578 | 0.91 | — | — | |
| SCHEMBL3782878 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111544655-B | Bisphosphonate type self-coagulation composite bone graft and preparation method thereof | 中鼎凯瑞科技成都有限公司 | 2022-06-24 | — | — | CN | claimed |
| US-20140255459-A1 | METHOD OF SURFACE TREATMENT OF MICRO/NANOPARTICLES BY CHEMICAL MEANS AND ITS APPLICATION TO OBTAINING A PIGMENT COMPOSITION INTENDED FOR THE FIELD OF COSMETICS, PAINT OR INKS | SIKEMIA (FR) | 2014-09-11 | — | — | US | claimed |
| EP-0002485-B1 | PROCESS FOR THE PREPARATION OF MARKING COMPOSITIONS CONTAINING TIN | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-04-28 | — | — | EP | claimed |
| US-20260115353-A1 | HYDROLYZED COLLAGEN COMPOSITIONS WITH ANTIBIOTICS AND METHODS OF USING THE SAME | ROCHAL TECHNOLOGIES, LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260102455-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL TECHNOLOGIES, LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260077023-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN WITH POLYLYSINE AND METHODS OF USING THE SAME | ROCHAL TECHNOLOGIES, LLC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2025085641-A1 | THE SYNTHESIS AND CHARACTERIZATION OF END-GROUP MODIFIED POLOXAMERS | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2025-04-24 | — | — | WO | disclosed |
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | ROCHAL TECHNOLOGIES LLC (US) | 2024-09-17 | — | — | US | disclosed |
| CN-117943110-A | Hydrogenation catalyst, preparation method thereof and method for preparing BTX (benzene-toluene-xylene) from refined light aromatic-rich distillate oil | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-110317230-B | Phosphate derivatives and use thereof | 上海昇悦医药科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116924436-A | Continuous preparation method of sodium sulfate, hydrogen peroxide and sodium chloride composite salt | 绍兴上虞洁华化工有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-1381406-A1 | ENHANCED CHRONIC LEAD REMOVAL | Medtronic, Inc. (US) | 2004-01-21 | — | — | EP | disclosed |
| WO-2003090808-A1 | BRANCHED POLYTHYLENE OXIDE TERMINATED BIOMEDICAL POLYMERS AND THEIR USE IN BIOMEDICAL DEVICES | MEDTRONIC, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| WO-2003090804-A1 | IMPLANTABLE MEDICAL DEVICE HAVING BIOLOGICALLY ACTIVE POLYMERIC CASING | MEDTRONIC, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030204229-A1 | Implantable medical device having biologically active polymeric casing | MEDTRONIC, INC. | 2003-10-30 | — | — | US | disclosed |
| US-20030204230-A1 | Branched polyethylene oxide terminated biomedical polymers and their use in biomedical devices | MEDTRONIC, INC. | 2003-10-30 | — | — | US | disclosed |
| US-20030028224-A1 | Enhanced chronic lead removal | MEDTRONIC, INC. | 2003-02-06 | — | — | US | disclosed |
| WO-2002085425-A1 | ENHANCED CHRONIC LEAD REMOVAL | MEDTRONIC, INC. (US) | 2002-10-31 | — | — | WO | disclosed |
| US-4689123-A | Novel tetraphosphonic acid compounds, intermediates and a process for their production | THE DOW CHEMICAL COMPANY (US) | 1987-08-25 | — | — | US | disclosed |
| EP-0002485-A1 | Process for the preparation of marking compositions containing tin | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-06-27 | — | — | EP | disclosed |